Application of CRISPR–cas-based technology for the identification of tuberculosis, drug discovery and vaccine development
Article in Molecular Biology Reports (March 2024)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
A dual-plasmid CRISPR/Cas9-based method for rapid and efficient genetic disruption in Mycobacterium abscessus
Article in Journal of Bacteriology (February 2024)
Phage therapy to combat mycobacterial infections: a therapeutic perspective
Article in Minerva Biotechnology and Biomolecular Research (January 2024)